Use of Diagnostic Testing for Managing Hepatitis C Virus Infection

Andrea Ferreira-Gonzalez; Mitchell L. Shiffman

doi:10.1055/s-2004-832923

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000069.xml

Share / Bookmark

Facebook Linkedin Weibo

Download PDF

Semin Liver Dis 2004; 24: 9-18
DOI: 10.1055/s-2004-832923

Use of Diagnostic Testing for Managing Hepatitis C Virus Infection

Andrea Ferreira-Gonzalez¹ , Mitchell L. Shiffman²

¹Division of Molecular Diagnostics, Department of Pathology, Virginia Commonwealth University Medical Center, Richmond, Virginia
²Department of Hepatology Section, Virginia Commonwealth University Medical Center, Richmond, Virginia

Further Information

Publication History

Publication Date:
02 September 2004 (online)

Abstract
Full Text
References

Buy Article Permissions and Reprints

Serological and virological testing for the hepatitis C virus (HCV) is essential in the management of patients with chronic HCV infection. Recent advances in molecular virology tests and the development of a new international unit standard have greatly simplified the use and interpretation of these tests. In the absence of treatment, baseline serum HCV RNA does not change over time and does not correlate with the severity of hepatic inflammation or fibrosis on liver biopsy. In contrast, changes in serum HCV RNA level are important predictors of virological response to treatment with pegylated interferon and ribavirin.

KEYWORDS

Hepatitis C - diagnosis - polymerase chain reaction - enzyme-linked immunoabsorbent assay - branched-chain DNA assay

REFERENCES

1 Choo Q L, Kuo G, Weiner A J et al.. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244 359-362

Crossref PubMed Search in Google Scholar
2 Kuo G, Choo Q L, Alter H J et al.. An assay for circulating antibodies to the major etiologic virus of human non-A, non-B hepatitis. Science. 1989; 244 362-364

Crossref PubMed Search in Google Scholar
3 Alter H J, Purcell R H, Shih J W et al.. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989; 321 1494-1500

Crossref PubMed Search in Google Scholar
4 Gretch D R. Use and interpretation of HCV diagnostic tests in the clinical setting. Clin Liver Dis. 1977; 1 543-557

PubMed Search in Google Scholar
5 Zaaijer H L, Cuypers H T, Reesink H W et al.. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet. 1993; 341 722-724

Crossref PubMed Search in Google Scholar
6 Saldanha J, Lelie N, Heath A. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO collaborative study group. Vox Sang. 1999; 76 149-158

Crossref PubMed Search in Google Scholar
7 Simmonds P. Variability of hepatitis C virus. Hepatology. 1995; 21 570-583

Crossref PubMed Search in Google Scholar
8 Fried M W, Hadziannis S. Treatment of chronic hepatitis C infection with peginterferons plus ribavirin. Semin Liver Dis. 2004; 24(suppl 2) 47-54

Thieme Connect PubMed Search in Google Scholar
9 Schiff E R, de Medina M, Kahn R S. New perspectives in the diagnosis of hepatitis C. Semin Liver Dis. 1999; 19 3-15

PubMed Search in Google Scholar
10 Gretch D R. Diagnostic tests for hepatitis C. Hepatology. 1997; 26(suppl) 43S-47S

Crossref PubMed Search in Google Scholar
11 Kao J H, Lai M Y, Hwang Y T et al.. Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay: a clinicopathologic study and demonstration of the usefulness of a third-generation assay. Dig Dis Sci. 1996; 41 161-165

PubMed Search in Google Scholar
12 Barrera J, Prancis B, Ercilla G et al.. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang. 1995; 68 15-18

PubMed Search in Google Scholar
13 Fried M W, Draguesku J O, Shindo M et al.. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci. 1993; 38 631-636

Crossref PubMed Search in Google Scholar
14 Alter M J. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis. 1997; 1 559-568

PubMed Search in Google Scholar
15 Thio C L, Nolt K R, Astemborski J et al.. Screening for hepatitis C virus in human immunodeficiency virus -infected individuals. J Clin Microbiol. 2000; 38 575-577

PubMed Search in Google Scholar
16 Colin C, Lanoir D, Touzet S et al.. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat. 2001; 8 87-95

Crossref PubMed Search in Google Scholar
17 Pawlotsky J M. Use and interpretation of hepatitis C virus diagnostic assays. Clin Liver Dis. 2003; 7 127-137

PubMed Search in Google Scholar
18 Alter H J, Tegtmeier G, Jett B et al.. The use of recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors and random donors. Transfusion. 1991; 31 771-776

Crossref PubMed Search in Google Scholar
19 Evans C, Tobler L, Polito A et al.. Comparative evaluations of supplemental hepatitis C virus antibody test systems. Transfusion. 1992; 32 408-414

Crossref PubMed Search in Google Scholar
20 Bouvier-Alias M, Patel K, Dahari H et al.. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology. 2002; 36 211-218

Crossref PubMed Search in Google Scholar
21 Lagging L M, Garcia C E, Westin J et al.. Comparison of serum hepatits C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol. 2002; 40 4224-4229

Crossref PubMed Search in Google Scholar
22 Vellion P, Payan C, Picchio G et al.. Comparative evaluation of the total hepatits C virus core antigen, branched-DNA, and Amplicor monitor assays in determining viremia for patients with chronic hepatits C during interferon plus ribavirin combination therapy. J Clin Microbiol. 2003; 41 3212-3220

Crossref PubMed Search in Google Scholar
23 Sarrazin C. Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance. J Clin Virol. 2002; 25(Suppl 3) S23-S29

PubMed Search in Google Scholar
24 Pawlotsky J M. Molecular diagnosis of viral hepatitis. Gastroenterology. 2002; 122 1554-1568

PubMed Search in Google Scholar
25 Zaaijer H L, Cuypers H T, Reesink H W et al.. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet. 1993; 341 722-724

Crossref PubMed Search in Google Scholar
26 Nolte F S, Fried M W, Shiffman M L et al.. Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests. J Clin Microbiol. 2001; 39 4005-4012

Crossref PubMed Search in Google Scholar
27 Komurian-Pradel F, Paranhos-Baccala G, Sodoyer M et al.. Quantitation of HCV RNA using real-time PCR and fluorimetry. J Virol Methods. 2001; 95 111-119

Crossref PubMed Search in Google Scholar
28 Kleiber J, Walter T, Haberhausen G et al.. Performance characteristics of a quantitative, homogeneous TaqMan RT-PCR test for HCV RNA. J Mol Diagn. 2000; 2 158-166

PubMed Search in Google Scholar
29 Kawai S, Yokosuka O, Kanda T et al.. Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV Amplicor Monitor assay. J Med Virol. 1999; 58 121-126

Crossref PubMed Search in Google Scholar
30 Hendricks D A, Friesenhahn M, Tanimoto L et al.. Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA. J Clin Microbiol. 2003; 41 651-656

Crossref PubMed Search in Google Scholar
31 Hill C S. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Rev Mol Diagn. 2001; 1 445-455

Crossref PubMed Search in Google Scholar
32 Sarrazin C, Teuber G, Kokka R, Rabenau H, Zeuzem S. Detection of residual hepatitis C virus RNA by transcription mediated amplification in patients with complete virologic response according to polymerase chain reaction-based asays. Hepatology. 2000; 32 818-823

Crossref PubMed Search in Google Scholar
33 Urdea M S, Horn T, Fultz T J et al.. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Symp Ser. 1991; 24 197-200

PubMed Search in Google Scholar
34 Pawlotsky J M, Martinot-Peignoux M, Poveda J D et al.. Quantification of hepatitis C RNA in serum by branched chain DNA-based signal amplification assays. J Virol Methods. 1999; 79 227-235

Crossref PubMed Search in Google Scholar
35 Fang J WS, Chow V, Lau J NY. Virology of hepatitis C virus. Clin Liver Dis. 1997; 1 493-514

PubMed Search in Google Scholar
36 Stuyver L, Wyseur A, van Arnhem W et al.. Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypable samples. Virus Res. 1995; 38 137-157

Crossref PubMed Search in Google Scholar
37 Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol. 1996; 34 2259-2266

PubMed Search in Google Scholar
38 Zheng X, Pang M, Chan A et al.. Direct comparison of hepatitis C virus genotypes tested by INNO-LiPA HCV II and TRUGENE HCV genotyping methods. J Clin Virol. 2003; 28 214-216

Crossref PubMed Search in Google Scholar
39 Anderson J C, Simonetti J, Fisher D G et al.. Comparison of different HCV viral load and genotyping assays. J Clin Virol. 2003; 28 27-37

Crossref PubMed Search in Google Scholar
40 Nakao T, Enomoto N, Takada N, Takada A, Date T. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol. 1991; 72 2105-2112

PubMed Search in Google Scholar
41 De Cock L, Vranckx R. Serotyping and genotyping of hepatitis C virus in Belgium. Infection. 2003; 31 92-97

Crossref PubMed Search in Google Scholar
42 Pawlotsky J M, Prescott L, Simmonds P et al.. Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. J Clin Micrbiol. 1997; 35 1734-1739

PubMed Search in Google Scholar
43 Pawlotsky J M, Bouvier-Alias M, Hezode C et al.. Standardization of hepatitis C virus RNA quantification. Hepatology. 2000; 32 654-657

Crossref PubMed Search in Google Scholar
44 Shiffman M L, Ferreria-Gonzalez A, Reddy K R et al.. Comparison of three commercially available assays for HCVRNA utilizing the international unit standard: Implications for management of patients with chronic hepatitis C virus infection in clinical practice. Am J Gastroenterol. 2003; 98 1159-1166

Crossref PubMed Search in Google Scholar
45 Krajden M, Ziermann R, Khan A et al.. Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay. J Clin Microbiol. 2002; 40 2903-2907

Crossref PubMed Search in Google Scholar
46 Yu M L, Chuang W L, Dai C Y et al.. Clinical evaluation of the automated Cobas Amplicor HCV Monitor test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the Quantiplex HCV Version 2.0 test. J Clin Microbiol. 2000; 38 2933-2939

PubMed Search in Google Scholar
47 Nguyen T, Sedghi-Vaziri A, Wilkes L et al.. Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection. J Viral Hepat. 1996; 3 75-78

PubMed Search in Google Scholar
48 Fried M W, Shiffman M L, Reddy K R et al.. Combination of peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection. N Engl J Med. 2002; 347 975-982

Crossref PubMed Search in Google Scholar
49 Davis G L, Wong J B, McHutchison J G et al.. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology. 2003; 38 645-652

PubMed Search in Google Scholar
50 Shiffman M L, Hofmann C M, Thompson E B et al.. Relationship between biochemical, virologic and histologic response during interferon treatment of chronic hepatitis C. Hepatology. 1997; 26 780-785

PubMed Search in Google Scholar
51 Shiffman M L, Hofmann C M, Contos M J et al.. A randomized, controlled trial of maintenance interferon for treatment of chronic hepatitis C non-responders. Gastroenterology. 1999; 117 1164-1172

Crossref PubMed Search in Google Scholar
52 Lee S. Histological response to interferon alfa-based therapies in hepatitis C. Semin Liver Dis. 2004; 24(suppl 2) 55-60

Thieme Connect PubMed Search in Google Scholar
53 Shiffman M L, Hofmann C M, Thompson E B et al.. Relationship between biochemical, virologic and histologic response during interferon treatment of chronic hepatitis C. Hepatology. 1997; 26 780-785

PubMed Search in Google Scholar
54 Zeuzem S, Heathcote E J, Shiffman M L et al.. Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C. J Hepatol. 2003; 39 106-111

PubMed Search in Google Scholar

Mitchell L ShiffmanM.D.

Hepatology Section, Virginia Commonwealth University Health System

Box 980341, Richmond, VA 23298

Email: mshiffma@hsc.vcu.edu